Articles tagged with Stem Cell Research
Researchers at the Buck Institute have confirmed that Parkinson's disease mutations alter mitochondrial function in human cells for the first time. The study provides a tool for testing potential therapeutics and promises to address concerns about genetic differences between patients.
A molecular pathway permits stem cells to grow rapidly and aggressively in pediatric bone cancers, according to researchers at NYU Langone Health. The transcription factor Sox2 releases the floodgates in the Hippo pathway, allowing for the growth of highly aggressive tumor-forming stem cells.
Scientists have discovered that the chromosomes in laboratory stem cells open slowly over time, allowing them to respond to growth factors and differentiate into specific cell types. This understanding could lead to advancements in stem cell research and the development of new therapies for diseases such as type 1 diabetes.
Researchers from Johns Hopkins Medicine discovered that premature aging of stem cell telomeres drives emphysema, not inflammation. This finding redirects research efforts to fix the underlying problem rather than treating symptoms.
Dr. Ayman Al-Hendy has received two top honors from the Society for Reproductive Investigation for his outstanding record of scientific investigation and promising research career. He is being recognized for his work on fibroids, uterine growths affecting up to 75% of women, which can complicate pregnancy and cause excessive bleeding.
A UCI team led by Leslie Thompson will establish an HD therapy employing human embryonic stem cells that can be evaluated in clinical trials. The researchers have identified a highly promising neural stem cell line showing disease-modifying activity in HD mice, and will conduct preclinical efficacy and safety studies.
The American Association of Anatomists has awarded Young Investigators to R.R. Bensley Award winner Bungo Akiyoshi for his discovery of unconventional kinetochores in Kinetoplastids, and Feng Zhang for his contributions to comparative neuroanatomy through genome manipulations using CRISPR-Cas9.
A stem cell-based approach using human embryonic stem cells proved effective in improving insulin sensitivity and glucose metabolism in mice. The combination of stem cell transplantation and antidiabetic drugs resulted in rapid weight loss and significant improvements in glucose control compared to individual treatments.
Researchers have identified a critical molecular pathway in blood stem cells that can be manipulated to enhance their regenerative capacity and reduce the signs of aging. By slowing down mitochondrial activity, they found that levels of SIRT7 can help cope with stress caused by misfolded proteins.
Researchers at Rockefeller University identified Sox9 as a key molecule controlling stem cell plasticity in hair follicles. Sox9 enables hair follicle stem cells to regain their ability to produce new tissue and heal wounds by amplifying genes associated with stemness.
Researchers at University of British Columbia found a new approach to treating Type 2 diabetes using stem cell transplants and conventional drugs. The study showed mice became glucose tolerant after receiving the transplants, while those without received only drugs, resulting in unexpected weight loss.
Researchers used super-resolution microscopy to visualize genome packaging and found that nucleosomes are assembled in irregular groups across the chromatin. This study reveals a link between genome packaging and cell pluripotency, with more pluripotent stem cells having less dense nucleosome clutches.
A new study by University of Alberta researchers found that media coverage of stem cell therapies often presents unrealistic timelines and overhypes the field. The study examined 307 news reports between 2010 and 2013, revealing that 69% predicted therapies would be available within 5-10 years or sooner.
A team of scientists has successfully repaired the damaged cerebral cortex of adult mice using cortical neurons derived from embryonic stem cells. The study suggests that only neurons of the same type as the damaged area can restore damaged circuits, providing new hope for treating brain injuries and diseases.
Scientists have made a breakthrough in treating patients with sickle cell disease by engineering custom blood cells that can evade the immune system. Lab-grown stem cells were reprogrammed and edited using CRISPR to replace the defective gene, resulting in healthy red blood cells that function just as well as those from unaffected donors.
The New York Stem Cell Foundation (NYSCF) has proposed seven strategies to advance women in science, engineering, and medicine, including flexible family care spending and recruiting gender-balanced review committees. The initiatives aim to promote gender equality and break down barriers to advancement in these fields.
A new study finds that Republicans generally defer to science on most issues, with only four exceptions: global warming, evolution, gay adoption, and mandatory health insurance. The study reveals that Republicans are more likely to trust science than independents and Democrats across a range of policy areas.
Researchers have devised a clonal strategy to ensure adult epidermal stem cells meet the highest safety criteria before use in treatments. The approach involves cultivating, genetically modifying and testing individual cells to guarantee their viability and safety.
Columbia University researchers successfully converted human skin cells into hypothalamic neurons, a type that regulates appetite. These neurons provide a patient-specific model for studying the neurophysiology of weight control and testing potential therapies.
Lene Oddershede's work focuses on merging physics, biology, and medicine to develop new treatments for diseases. Her award-winning research includes the creation of Scandinavia's first optical tweezers, which enable the study of individual cells and molecules without damaging surrounding tissues.
A new study at The Scripps Research Institute shows that certain stem cell culture conditions can reduce DNA mutations. Researchers developed a method using feeder cells and manual passaging to minimize genetic instability.
Researchers at UC San Diego School of Medicine found that culture conditions and passage methods affect genetic stability in human stem cells. The study highlights the need for quality control to ensure the safety of transplanted stem cells.
Researchers discovered that increased levels of retinoic acid reduce blood cell production, while lower levels increase it by 300%. This finding supports the need for pregnant women to limit their vitamin A intake. The study also contributes to the development of artificial blood stem cells for patients with blood disorders.
Researchers at the University of Pittsburgh School of Medicine have found that wisdom teeth stem cells can transform into corneal cells to repair scarring. The discovery could lead to new treatments for corneal blindness, a condition affecting millions worldwide.
State-funded programs in California and Connecticut have contributed to an increase in stem-cell-related publications, with California benefiting most. The study suggests that state funding has established California as a leader in this emerging field, while Maryland and New York saw minimal impact on publication trends.
Researchers at Queen Mary University of London found that regulating primary cilia length in stem cells can prevent the production of new fat cells. This study provides new insight into the regulation of fat cell formation and obesity, potentially leading to a new type of treatment called 'cilia-therapy'.
Researchers at the University of Cambridge discovered that the order of genetic mutations acquired determines how cancer behaves. The study found that patients who acquire mutations in JAK2 prior to those in TET2 are more likely to develop a severe red blood cell disease subtype and suffer from blood clots.
Researchers at the University of Minnesota Academic Health Center have developed a new reporter system to study bone regeneration potential in human embryonic stem cells. The system allows for better monitoring of cell properties and may lead to the creation of new therapies for diseases such as leukemia or genetic blood disorders.
A new study by Sanford-Burnham Medical Research Institute has identified a specific stem cell signaling process that regulates intestinal tumors. The findings suggest that protein kinase C-zeta inhibits stem cell activity through downregulation of two signaling pathways: beta-catenin and Yap.
Scientists at Gladstone Institutes have discovered a way to enhance CRISPR's precision while boosting its efficiency using small molecules. This breakthrough has important implications for correcting disease-causing genetic mutations and creating personalized therapeutics.
MIT researchers have engineered a way to use human liver cells to screen potential antimalarial drugs and vaccines for their ability to treat the liver stage of malaria infection. The approach may offer new opportunities for personalized antimalarial drug testing.
Human stem cells have been shown to repair damage caused by radiation therapy for brain cancer in rats, regaining cognitive and motor functions lost after treatment. The study uses human embryonic stem cells or induced pluripotent stem cells to replace damaged oligodendrocyte progenitor cells.
Researchers at the University of Gothenburg and Karolinska Institute have failed to successfully treat infertility with stem cells, contradicting previous claims. The study shows that female mice can only produce eggs from birth, rendering stem cell-based treatment unrealistic.
Researchers at Keck Medicine of USC have received grants to develop a temporary liver support system for transplant patients and improve gene editing for blood diseases. They also plan to create transgenic rats for researching heart failure, diabetes, and neurodegenerative diseases.
A San Diego team has won a $1.7 million grant to develop quality control methods for stem cells, enabling researchers to detect abnormal cells and ensure the safety and efficacy of potential therapies.
Researchers at Cedars-Sinai Medical Center have developed a novel method to generate transplantable corneal stem cells, which may benefit patients with life-altering forms of blindness. The study shows that these cells can differentiate into corneal cells in the laboratory, offering a promising treatment option.
Scientists have developed a breakthrough culturing system for human liver stem cells and pancreatic cancer stem cells, allowing for the growth of mini-organisms in the lab. This technology has the potential to revolutionize liver transplantation and aid in the fight against pancreatic cancer, with applications in personalized medicine.
Blood stem cells bud off from aorta, circulate until finding niche, then attach to vessel wall and interact with endothelial cells. The process involves chemical signals, cell attachment, and division to form blood system in zebrafish and possibly humans.
Researchers at Stanford University School of Medicine have discovered a stem cell in mice that gives rise to bone, cartilage and stroma. The discovery sets the stage for therapies for skeletal disorders such as bone fractures, brittle bones, and damaged cartilage.
Researchers have successfully improved muscle repair in mice with muscular dystrophy by increasing the BMI1 gene, leading to increased strength and longer treadmill runs. The study provides a proof of concept for harnessing this gene to enhance muscle regeneration and may lead to new treatments for patients.
Researchers at Northwestern University have developed a novel microfluidic device that allows for electroporation of adherent stem cells during differentiation, enabling the delivery of molecules in a non-destructive manner. This breakthrough has the potential to advance fundamental knowledge and state-of-the-art in stem cell research.
Professor Warburton's book, Stem Cells, Tissue Engineering and Regenerative Medicine, surveys current issues in stem cell biology and regenerative medicine. The book provides overviews of recent progress in stem cell research, including progenitor cell therapies for organ systems.
Belgian researchers used patient-derived stem cells to model frontotemporal dementia, a condition that affects about half of dementia cases before age 60. The study found a targetable defect in the Wnt signaling pathway, which can be corrected with genetic therapy or compounds inhibiting this pathway.
Researchers at the University of Copenhagen have discovered a way to promote stem cell growth by inhibiting their ability to make decisions. By blocking key choices, embryonic stem cells can be transformed into more efficient cell types, potentially leading to breakthroughs in cancer treatment and gut-related disorder therapies.
Researchers at Stanford University School of Medicine found that faulty stem cells surrounding muscle fibers are responsible for the progression of Duchenne muscular dystrophy. A drug called losartan has been shown to inhibit fibrosis and partially restore muscle function in laboratory mice, offering new hope for potential treatments.
Scientists at Indiana University and colleagues have demonstrated a technique for correcting genetic mutations in sperm-producing adult stem cells, a breakthrough that could prevent inherited defects in future generations. The method uses homologous recombination to repair flawed segments of DNA with correct ones.
Researchers find that embryonic stem cells can modify their metabolism to keep their entire genome accessible, allowing them to renew themselves. This discovery could lead to breakthroughs in regenerative medicine and a better understanding of cancer.
Scientists have developed a method to transmute living cells into more permanent materials that defy rot and can endure high-powered probes. This technique is widening research opportunities for biologists developing cancer treatments and materials scientists creating commercially useful shapes.
Researchers at Harvard University have developed a system using human stem cells to screen for compounds that can turn white, or 'bad', fat cells into brown, or 'good' fat cells. They have identified two compounds that can accomplish this in human cells, taking the first step towards a potential pill for obesity treatment.
A team of scientists found that a specific chemical modification on RNA plays a key role in determining the ability of embryonic stem cells to adopt different cellular identities. Depleting or knocking out this component blocks stem cells from differentiating into specialized types of cells.
Researchers have identified new ways to regulate and control the growth of various cell and tissue types by analyzing individual stem cells' genetic makeup. The findings reveal a complex
Scientists at McMaster University have discovered that human induced pluripotent stem cells retain a memory of their original tissue type, allowing for more targeted regeneration and therapy development. This breakthrough challenges the conventional thought that any pluripotent human stem cell can be used to generate mature tissue cells.
Fibrotic diseases cause up to 45 percent of deaths worldwide. Researchers identified Gli1 cells around blood vessels as responsible for fibrosis. Abating these cells improved organ function in mice with kidney and cardiac fibrosis.
Scientists at Cedars-Sinai Medical Center have developed a method to re-create stem cells from stored blood samples of deceased patients. This approach enables researchers to study the biological mechanisms behind diseases and potentially design new therapies for conditions such as Crohn's disease.
Researchers at Harvard University have identified a rare population of stem cells that give rise to fibrosis, a condition characterized by the buildup of scar tissue in organs. The study suggests that targeting these stem cells could lead to therapeutic breakthroughs for conditions such as diabetes, lung disease, and high blood pressure.
Researchers at USC Health Sciences identified a new population of nail stem cells that can self-renew or differentiate into multiple tissues, including nail and skin. These stem cells play a crucial role in nail repair, but their potential to generate additional types of tissue is still unknown.
Researchers at Mount Sinai aim to re-create patients' ocular stem cells to restore vision, eliminating the need for immunosuppressive drugs. The grant will support efforts to discover new stem cell therapies and develop biomaterials for engrafting patient-owned stem cells.
Researchers found that administering stem cell factor directly into damaged heart muscle after a heart attack can help repair and regenerate injured tissue. The study showed improved cardiac function, reduced cell death, and increased regeneration of heart tissue blood vessels.
Researchers at Cedars-Sinai Medical Center have found that injections of cardiac stem cells may help reverse heart damage caused by Duchenne muscular dystrophy, potentially leading to improved heart function and exercise capacity. The study involved laboratory mice infused with cardiac stem cells, which showed marked improvement in hea...
A study by Stanford University School of Medicine researchers reveals that the protein retinoblastoma, a known tumor suppressor, also inhibits the vital property of pluripotency in stem cells. This finding provides a direct molecular link between cancer and stem cell science.